Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Biochips (Microarrays/Microfluidics) Market by Type (DNA Chip, Lab-on-a-chip, Protein Chip), By Application (Academics Institutes, Diagnostics Centers) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Biochips (Microarrays/Microfluidics) Market by Type (DNA Chip, Lab-on-a-chip, Protein Chip), By Application (Academics Institutes, Diagnostics Centers) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 130053 3300 Medical Devices & Consumables 377 230 Pages 5 (42)

Market Overview:

The global biochips market is expected to grow at a CAGR of 10.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for biochips in academic institutes and diagnostic centers for research and development purposes, respectively. Additionally, the growing application of biochips in drug discovery and personalized medicine is also contributing significantly to the growth of this market. On the basis of type, DNA chip held a dominant position in 2017 and is expected to maintain its dominance throughout the forecast period. This can be attributed to their high adoption rate for gene expression profiling, SNP genotyping, methylation analysis, etc., across various end-use applications.

Global Biochips (Microarrays/Microfluidics) Industry Outlook

Product Definition:

Biochips (Microarrays/Microfluidics) are devices that allow for the automated testing of large numbers of biological samples. They can be used to test for the presence or absence of a particular gene, to identify mutations in a gene, or to determine the amount of a particular protein present in a sample. Biochips are important because they allow for rapid and accurate diagnosis of diseases and disorders.

DNA Chip:

DNA chips are used for the detection and analysis of specific gene or protein sequences. It is a high-throughput technique that allows researchers to simultaneously test many samples at once, which has made it an important tool in molecular biology. The technology is relatively new; hence its applications are also limited only by our knowledge and understanding of its potential uses.


A lab-on-a-chip is a device that performs multiple functions in one small space. It can be used for biological or chemical analysis and it helps save time by eliminating the need to run multiple tests on samples. The technology has been around for more than a decade but has only recently started to gain widespread attention due to its potential use in microfluidics and microarrays, two emerging fields of biotechnology/bioinformatics.

Application Insights:

The academic institutes segment dominated the global market in terms of revenue in 2017. This is attributed to rising demand for biochips from various research projects and studies conducted at academic institutes. In addition, growing R&D activities pertaining to microfluidics and lab-on-a-chip technology are further expected to propel product demand over the forecast period.

Diagnostics centers are anticipated to witness lucrative CAGR during the forecast period owing to increasing adoption of advanced diagnostic techniques, such as immunoassays and flow cytometry, which require a large number of biochips per day for diagnosis within a short span of time. Furthermore, an increase in chronic diseases such as cancer is also expected fuel product demand during the forecast period.

Regional Analysis:

North America dominated the global market in 2017. This can be attributed to presence of a large number of players, high adoption rate for advanced technologies, and increasing focus on drug discovery & development. The region is expected to maintain its position during the forecast period owing to continuous innovations and technological advancements in microarray technology.

Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to rising investments by governments for developing biochips-based diagnostic products at relatively lower costs as compared with conventional methods used across various countries. In addition, growing awareness about early disease diagnosis coupled with rapidly improving healthcare infrastructure are some factors that can be attributed for rapid increase in demand from Asia Pacific region during the forecast period (2018 - 2030). Moreover, increasing R&D activities relatedto personalized medicineis also expected drive regional growth over next eight years  (2030).

Growth Factors:

  • Increasing demand for personalized medicine
  • Growing prevalence of chronic diseases
  • Technological advancements in biochip technology
  • Rising investments in life sciences and biotechnology sector
  • Growing number of collaborations and partnerships among biochip manufacturers

Scope Of The Report

Report Attributes

Report Details

Report Title

Biochips (Microarrays/Microfluidics) Market Research Report

By Type

DNA Chip, Lab-on-a-chip, Protein Chip

By Application

Academics Institutes, Diagnostics Centers

By Companies

Abbott, Agilent, PerkinElmer, Fluidigm, Illumina, GE Healthcare, Bio-Rad Laboratories, Cepheid, Thermo Fisher, Roche

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year


Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year


Number of Pages


Number of Tables & Figures


Customization Available

Yes, the report can be customized as per your need.

Global Biochips (Microarrays/Microfluidics) Market Report Segments:

The global Biochips (Microarrays/Microfluidics) market is segmented on the basis of:


DNA Chip, Lab-on-a-chip, Protein Chip

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.


Academics Institutes, Diagnostics Centers

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Abbott
  2. Agilent
  3. PerkinElmer
  4. Fluidigm
  5. Illumina
  6. GE Healthcare
  7. Bio-Rad Laboratories
  8. Cepheid
  9. Thermo Fisher
  10. Roche

Global Biochips (Microarrays/Microfluidics) Market Overview

Highlights of The Biochips (Microarrays/Microfluidics) Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. DNA Chip
    2. Lab-on-a-chip
    3. Protein Chip
  1. By Application:

    1. Academics Institutes
    2. Diagnostics Centers
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Biochips (Microarrays/Microfluidics) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Biochips (Microarrays/Microfluidics) Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?

Biochips are microarrays and microfluidics devices that can be used to detect, identify, and quantify a variety of biological molecules. Biochips can be used for a variety of applications including drug discovery, diagnostics, and environmental monitoring.

Some of the major players in the biochips (microarrays/microfluidics) market are Abbott, Agilent, PerkinElmer, Fluidigm, Illumina, GE Healthcare, Bio-Rad Laboratories, Cepheid, Thermo Fisher, Roche.

The biochips (microarrays/microfluidics) market is expected to grow at a compound annual growth rate of 10.8%.

1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Biochips (Microarrays/Microfluidics) Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Biochips (Microarrays/Microfluidics) Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Biochips (Microarrays/Microfluidics) Market - Supply Chain
   4.5. Global Biochips (Microarrays/Microfluidics) Market Forecast
      4.5.1. Biochips (Microarrays/Microfluidics) Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Biochips (Microarrays/Microfluidics) Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Biochips (Microarrays/Microfluidics) Market Absolute $ Opportunity

5. Global Biochips (Microarrays/Microfluidics) Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Biochips (Microarrays/Microfluidics) Market Size and Volume Forecast by Type
      5.3.1. DNA Chip
      5.3.2. Lab-on-a-chip
      5.3.3. Protein Chip
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Biochips (Microarrays/Microfluidics) Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Biochips (Microarrays/Microfluidics) Market Size and Volume Forecast by Application
      6.3.1. Academics Institutes
      6.3.2. Diagnostics Centers
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Biochips (Microarrays/Microfluidics) Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Biochips (Microarrays/Microfluidics) Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Biochips (Microarrays/Microfluidics) Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Biochips (Microarrays/Microfluidics) Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Biochips (Microarrays/Microfluidics) Demand Share Forecast, 2019-2029

9. North America Biochips (Microarrays/Microfluidics) Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Biochips (Microarrays/Microfluidics) Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Biochips (Microarrays/Microfluidics) Market Size and Volume Forecast by Application
      9.4.1. Academics Institutes
      9.4.2. Diagnostics Centers
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Biochips (Microarrays/Microfluidics) Market Size and Volume Forecast by Type
      9.7.1. DNA Chip
      9.7.2. Lab-on-a-chip
      9.7.3. Protein Chip
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Biochips (Microarrays/Microfluidics) Demand Share Forecast, 2019-2029

10. Latin America Biochips (Microarrays/Microfluidics) Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Biochips (Microarrays/Microfluidics) Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Biochips (Microarrays/Microfluidics) Market Size and Volume Forecast by Application
      10.4.1. Academics Institutes
      10.4.2. Diagnostics Centers
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Biochips (Microarrays/Microfluidics) Market Size and Volume Forecast by Type
      10.7.1. DNA Chip
      10.7.2. Lab-on-a-chip
      10.7.3. Protein Chip
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Biochips (Microarrays/Microfluidics) Demand Share Forecast, 2019-2029

11. Europe Biochips (Microarrays/Microfluidics) Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Biochips (Microarrays/Microfluidics) Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Biochips (Microarrays/Microfluidics) Market Size and Volume Forecast by Application
      11.4.1. Academics Institutes
      11.4.2. Diagnostics Centers
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Biochips (Microarrays/Microfluidics) Market Size and Volume Forecast by Type
      11.7.1. DNA Chip
      11.7.2. Lab-on-a-chip
      11.7.3. Protein Chip
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Biochips (Microarrays/Microfluidics) Demand Share, 2019-2029

12. Asia Pacific Biochips (Microarrays/Microfluidics) Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Biochips (Microarrays/Microfluidics) Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Biochips (Microarrays/Microfluidics) Market Size and Volume Forecast by Application
      12.4.1. Academics Institutes
      12.4.2. Diagnostics Centers
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Biochips (Microarrays/Microfluidics) Market Size and Volume Forecast by Type
      12.7.1. DNA Chip
      12.7.2. Lab-on-a-chip
      12.7.3. Protein Chip
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Biochips (Microarrays/Microfluidics) Demand Share, 2019-2029

13. Middle East & Africa Biochips (Microarrays/Microfluidics) Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Biochips (Microarrays/Microfluidics) Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Biochips (Microarrays/Microfluidics) Market Size and Volume Forecast by Application
      13.4.1. Academics Institutes
      13.4.2. Diagnostics Centers
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Biochips (Microarrays/Microfluidics) Market Size and Volume Forecast by Type
      13.7.1. DNA Chip
      13.7.2. Lab-on-a-chip
      13.7.3. Protein Chip
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Biochips (Microarrays/Microfluidics) Demand Share, 2019-2029

14. Competition Landscape
   14.1. Global Biochips (Microarrays/Microfluidics) Market: Market Share Analysis
   14.2. Biochips (Microarrays/Microfluidics) Distributors and Customers
   14.3. Biochips (Microarrays/Microfluidics) Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. Abbott Overview Financials Developments Strategic Outlook
      14.4.2. Agilent Overview Financials Developments Strategic Outlook
      14.4.3. PerkinElmer Overview Financials Developments Strategic Outlook
      14.4.4. Fluidigm Overview Financials Developments Strategic Outlook
      14.4.5. Illumina Overview Financials Developments Strategic Outlook
      14.4.6. GE Healthcare Overview Financials Developments Strategic Outlook
      14.4.7. Bio-Rad Laboratories Overview Financials Developments Strategic Outlook
      14.4.8. Cepheid Overview Financials Developments Strategic Outlook
      14.4.9. Thermo Fisher Overview Financials Developments Strategic Outlook
      14.4.10. Roche Overview Financials Developments Strategic Outlook
      14.4.11. COMPANY 11 Overview Financials Developments Strategic Outlook
      14.4.12. COMPANY 12 Overview Financials Developments Strategic Outlook
      14.4.13. COMPANY 13 Overview Financials Developments Strategic Outlook
      14.4.14. COMPANY 14 Overview Financials Developments Strategic Outlook
      14.4.15. COMPANY 15 Overview Financials Developments Strategic Outlook
      14.4.16. COMPANY 16 Overview Financials Developments Strategic Outlook
      14.4.17. COMPANY 17 Overview Financials Developments Strategic Outlook
      14.4.18. COMPANY 18 Overview Financials Developments Strategic Outlook
      14.4.19. COMPANY 19 Overview Financials Developments Strategic Outlook
      14.4.20. COMPANY 20 Overview Financials Developments Strategic Outlook

Our Trusted Clients

Contact Us